SEC 8-K
SEC 8-K: Item 3.03, 5.03, 9.01
Official SEC filing update. Items: 3.03, 5.03, 9.01.
Item 3.03, 5.03, 9.01Accession 0001666700-26-000046
DuPont (DD) Financials, Dividends & Stock Info
Explore comprehensive financial data for DuPont, provided completely free. Analyze revenue, net income, profit margins, dividend history, and key financial ratios to make informed investment decisions.
Data as of (572 days ago)|Source: SEC EDGAR
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
DuPont (DD) is a specialty chemicals company. The company reports annual revenue of $12.8B and net loss of $772M. Its profit margin is -6.0%.
DuPont Key Financials(TTM Est.)
Revenue (TTM)↓ 76.0%
$12.8B
Net Income (TTM)↓ 183.8%
$-772.0M
Profit Margin
-6.0%
Top 93% in sector
Return on Equity
-3.4%
Top 80% in sector
Data from SEC EDGAR filings. TTM = Trailing Twelve Months.
DuPont Financial Health ScoreFY2025
0/100
Weak financial health; requires careful evaluation
-11 pts YoYProfitability15Liquidity100Growth10Cash Flow80Efficiency18
This Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Data Highlights
- Altman Z-Score -0.01 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont Official SEC Updates
Official filing updates from SEC EDGAR. Billiver stores internal evidence snapshots for verification, but this page links to the SEC source instead of republishing full filing text.
Open SEC filing
SEC 8-K
SEC 8-K: Item 5.07, 7.01, 9.01
Official SEC filing update. Items: 5.07, 7.01, 9.01.
Item 5.07, 7.01, 9.01Accession 0001666700-26-000034
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001666700-26-000031
SEC 8-K
SEC 8-K: Item 2.02, 9.01
Official SEC filing update. Items: 2.02, 9.01.
Item 2.02, 9.01Accession 0001666700-26-000029
SEC 8-K
SEC 8-K: Item 5.02
Official SEC filing update. Items: 5.02.
Item 5.02Accession 0001666700-26-000025
Source: SEC EDGAR · 5 filings
Informational only. Not investment advice.
DuPont Recent Events
Governance Amendment
Shareholder Vote
Earnings Results
Leadership Change
Other Events
Source: SEC EDGAR 8-K Filings
5-Year Revenue & Net Income Trend
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Revenue Breakdown (FY2024)
See DuPont detailed breakdown →IndustrialSolutions
$1.9B15.5%
InterconnectSolutions
$1.8B14.7%
SafetySolutions
$2.4B19.2%
Showing top 3 of 7 segments
About DuPont
DuPont de Nemours, Inc., commonly shortened to DuPont, is an American multinational chemical company first formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. The company played a major role in the development of the U.S. state of Delaware and first arose as a major supplier of gunpowder. DuPont developed many polymers such as Vespel, neoprene, nylon, Corian, Teflon, Mylar, Kapton, Kevlar, Zemdrain, M5 fiber, Nomex, Tyvek, Sorona, viton, Corfam and Lycra in the 20th century, and its scientists developed many chemicals, most notably Freon (chlorofluorocarbons), for the refrigerant industry. It also developed synthetic pigments and paints including ChromaFlair.
- Industry
- Specialty Chemicals
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Thin MarginsROE-3.4%
vs 3.6% sector median / 6.2% avg
▼
Currently generating negative returns on shareholder equity.
Profit Margin-6.0%
vs 3.5% sector median / 3.5% avg
▼
Currently operating at a loss of 6 cents per dollar of revenue.
Revenue (TTM)*$12.8B
Net Income (TTM)*-$772M (Loss)
* Some quarterly data is missing. Values are calculated based on annual report figures.
Profit margin 270% below sector average.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Balance Sheet Data LimitedInsufficient data to assess financial health.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
DuPont 10-Year Revenue, Profit & Cash Flow History
Annual Financials
FY2025 - FY2016| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6B(-76.0%) | $6.7B(+1.6%) | $6.6B(-49.2%) | $13.0B(+3.6%) | $12.6B(-38.4%) | $20.4B(-5.2%) | $21.5B(-4.8%) | $22.6B(+93.6%) | $11.7B(-75.8%) | $48.2B(-1.3%) |
| Net Income | $-589,000,000(-183.8%) | $703.0M(+66.2%) | $423.0M(-92.8%) | $5.9B(-9.3%) | $6.5B(+319.1%) | $-2,951,000,000(-692.6%) | $498.0M(-87.0%) | $3.8B(+231.8%) | $1.2B(-73.2%) | $4.3B(-43.8%) |
| Total Assets | $21.6B | $36.6B | $38.6B | $41.4B | $45.7B | $70.9B | $69.3B | $187.9B | $191.9B | $79.5B |
| Total Debt | - | - | $7.9B | $8.1B | $10.6B | $15.6B | $-15,618,000,000 | $-12,635,000,000 | $32.1B | $21.1B |
| Total Equity | $13.9B | $23.4B | $24.3B | $26.6B | $26.4B | $38.5B | $41.0B | $94.3B | $100.3B | $27.3B |
| Profit Margin | -36.5% | 10.5% | 6.4% | 45.1% | 51.5% | -14.5% | 2.3% | 17.0% | 9.9% | 9.0% |
| ROE | -4.2% | 3.0% | 1.7% | 22.1% | 24.5% | -7.7% | 1.2% | 4.1% | 1.2% | 15.8% |
| ROA | -2.7% | 1.9% | 1.1% | 14.2% | 14.1% | -4.2% | 0.7% | 2.1% | 0.6% | 5.4% |
Quarterly Financials
Last 8 quarters| Metric | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6B | $8.3B | $6.1B | $2.9B | $9.2B | $6.1B | $3.0B | $9.9B |
| Net Income | $-589,000,000 | $822.0M | $367.0M | $189.0M | $445.0M | $126.0M | $257.0M | $1.6B |
| Total Assets | $21.6B | $36.6B | $36.6B | $36.6B | $38.6B | $38.6B | $38.6B | $41.4B |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Insider Trading
Loading chart...
Loading transactions...
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
DuPont Dividend Safety Analysis & Growth History
Dividend Status
Dividend PayerCAGR (5Y)
+0.5%
CAGR (10Y)
-3.3%
This company pays dividends. Historical dividend data shown below.
5-year dividend CAGR: +0.5%.
Annual Dividends
2016 - 2025| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend/Share | $1.84 | $1.76 | $4.56 | $2.16 | $1.20 | $1.20 | $1.32 | $1.44 | $1.52 | $1.23 |
| YoY Growth | +7.0% | -4.3% | +159.1% | -52.6% | -44.4% | +0.0% | +10.0% | +9.1% | +5.6% | -19.1% |
| Payments | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
| Increased | Yes | No | Yes | No | No | No | Yes | Yes | Yes | No |
Learn more: Dividend investing guide | How to evaluate dividend safety
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
DuPont Free Cash Flow & Dividend Coverage
Free Cash Flow
$227.0M
FY2025
FCF Margin
14.1%
FCF / Revenue
Operating Cash Flow
$560.0M
Cash from operations
FCF / Net Income
-0.39x
Below earnings
Cash Flow History
FY2016 - FY2025| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | -$3.0B | -$765.0M | $4.7B | $1.4B | $4.1B | $2.3B | $588.0M | $845.0M | $765.0M | $560.0M |
| CapEx | -$3.8B | -$551.0M | -$1.2B | -$2.5B | -$1.2B | -$788.0M | -$662.0M | -$302.0M | -$285.0M | -$333.0M |
| Free Cash Flow | -$6.8B | -$1.3B | $3.5B | -$1.1B | $2.9B | $1.5B | -$74.0M | $543.0M | $480.0M | $227.0M |
| FCF Margin | -14.0% | -11.3% | 15.4% | -4.9% | 14.2% | 11.9% | -0.6% | 8.2% | 7.1% | 14.1% |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
DuPont Risk Factors
Company-disclosed SEC risk factors
Risk factors are disclosed by the company in its SEC Form 10-K, Item 1A. Billiver does not classify or summarize company-specific legal, operational, financial, or market risks here.
Sector context: Materials. This is not a Billiver risk assessment for DD.
Source note: the SEC Form 10-K includes Item 1A, "Risk Factors." The full risk-factor text should be read from the company’s own SEC filing.
DuPont FAQ
What is DuPont's annual revenue?
DuPont (DD) reported $12.8 billion in trailing twelve-month (TTM) revenue. This financial data is compiled from SEC EDGAR 10-K filings.
Is DuPont profitable?
DuPont reported a net loss with a -6.0% profit margin, totaling $772 million in net losses (TTM). All figures from SEC EDGAR 10-K filings.
Does DuPont pay dividends?
Yes, DuPont pays regular dividends. View the full dividend history and payout analysis on this page.
What is DuPont's financial health score?
DuPont has a financial health score of 43/100 (Grade: F), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of DuPont financial data are available?
10 years of financial data are available for DuPont from FY2016 to FY2025. All figures are compiled from SEC EDGAR 10-K filings.